One of the most exciting possibilities arising from the recognition that cancer cells depend on glycolysis19, 20, 21 is the use of inhibitors of the various glycolytic enzymes, such as hexokinase, lactate dehydrogenase, ATP citrate lyase, phosphoglycerate mutase and pyruvate kinase as anticancer agents22, 23. This evidence concerns the gene ACLY and cancer.